Overview

The Effect of Methylphenidate on Cognitive Abilities of Adults With Bipolar Disorder

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to explore the effect of MPH on working memory, attention and decision making in adults with BD in remission or in depressed state. The results will be compared to findings in healthy adults and adults with ADHD. The investigators hypothesize that MPH will incur improved performance in all measures.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Shalvata Mental Health Center
Treatments:
Methylphenidate
Criteria
Inclusion Criteria:

- Hebrew Speakers

- Age 21-50

- Diagnosis of BD I or II (296.7 and 296.89 classifications in the DSM-IV-TR), according
to medical records. Diagnosis will be confirmed by a psychiatrist during screening
process using the Structured Clinical Interview for DSM-IV-TR (SCID).

Exclusion Criteria:

- Diagnosis of a clinical disorder other than BD or ADD/ADHD which may impair
performance on tasks used in the study.

- BD patients diagnosed with an acute manic episode at screening, as established by
YMRS>8. It will also be required that 3 months have elapsed since the latest manic
state, according to the patients' history.

- Participants for whom there exists a contra-indication for consuming Ritalin.

- Pregnancy or current breastfeeding; Female participants will be asked to report
whether they are pregnant or currently nursing and if so, they will be excluded from
the study.

- Drug use in the previous 6 weeks according to participants' self report

- Electroconvulsive therapy (ECT) in the previous 6 months